(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

USO DE UM DERIVADO DE TIENOPIRIDONA NO TRATAMENTO DE ADRENOLEUCODISTROFIA OU ADRENOMIELONEUROPATIA

Em AnáliseInvention PatentPCT · EP2021057988

Application data

Number

112022018731

Type

Invention Patent

Filing

03/26/2021

Publication

11/01/2022

PCT

EP2021057988

Progress at the INPI

  1. Filing03/26/21
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 03/26/2021. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 11/01/2022. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

POXEL

FR

See this company's full portfolio

Inventors

P. F. (pessoa física)

CH

S. B. (pessoa física)

FR

S. H. (pessoa física)

FR

Technical data

Priority claims

EP

20166035.4 · 03/26/2020

Abstract

USO DE UM DERIVADO DE TIENOPIRIDONA NO TRATAMENTO DE ADRENOLEUCODISTROFIA OU ADRENOMIELONEUROPATIA. A presente invenção refere-se ao uso de um derivado de tienopiridona ou uma composição farmacêutica compreendendo o mesmo, no tratamento de doenças neurodegenerativas genéticas selecionadas de adrenoleucodistrofia (ALD) e adrenomieloneuropatia (AMN).

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

11/01/2022

RPI 2704

Alteração de dados cadastrais

#1.1

09/27/2022

RPI 2699

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.